---
title: 'Manufacturing Daily Summary: What Happened on October 14, 2026'
headline: How compounding facilities can help fill drug-supply gaps
description: Fox Rothschild attorney Marc Wagner described the limited role of 503A
  pharmacies and 503B outsourcing facilities during shortages.
url: https://thebench.bio/news/manufacturing/2026-10-14
topic: manufacturing
date: '2026-10-14'
covers:
- '2026-10-14'
date_published: '2026-10-14T12:02:19Z'
date_modified: '2026-10-14T12:02:19Z'
tags:
- Industry
sources: 1
publisher: TheBench.Bio
---

# Manufacturing Daily Summary: What Happened on October 14, 2026

**How compounding facilities can help fill drug-supply gaps**

Fox Rothschild attorney Marc Wagner described the limited role of 503A pharmacies and 503B outsourcing facilities during shortages.

## Today in brief

Pharmaceutical Executive interviewed Fox Rothschild attorney Marc Wagner about how compounding pharmacies and outsourcing facilities can add limited supply during drug shortages. [1]

## Sources

1. [The Role That 503B Outsourcing and Compounding Pharmacies Actually Play in Filling Supply Gaps](<https://www.pharmexec.com/view/role-503b-outsourcing-compounding-actually-play-filling-supply-gaps>), Pharmaceutical Executive, 2026-10-14

---

TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://www.pharmexec.com/view/role-503b-outsourcing-compounding-actually-play-filling-supply-gaps>
